Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6394063 | 0.85 | SLC15A1 (0.53) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| Trifluoroacetic Acid SCHEMBL27745770 | 0.83 | LTA4H (0.47) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| SCHEMBL14682359 | 0.83 | ALDH1A1 (0.57) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| SCHEMBL14908324 | 0.83 | ALDH1A1 (0.57) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| Trifluoroacetic Acid SCHEMBL2367354 | 0.81 | ALDH1A1 (0.50) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| Trifluoroacetic Acid SCHEMBL27766342 | 0.81 | ALDH1A1 (0.50) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| Trifluoroacetic Acid SCHEMBL27959204 | 0.81 | DPP4 (0.49) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| SCHEMBL17137963 | 0.80 | SLC1A3 (0.47) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 | |
| SCHEMBL2367208 | 0.80 | CTSB (0.44) | SLC15A1KMT2AMEN1CYP2D6CYP2C9 | |
| SCHEMBL5196444 | 0.80 | SLC1A3 (0.55) | SLC15A1ALDH1A1KMT2AMEN1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2007794-B1 | LYSOBACTIN AMIDES | AICURIS GMBH & CO KG (DE) | 2011-09-14 | — | — | EP | disclosed |
| EP-2004670-B1 | PROCESS FOR THE MANUFACTURE OF LYSOBACTIN DERIVATIVES | AICURIS GMBH & CO KG (DE) | 2010-01-27 | — | — | EP | disclosed |
| US-20090163696-A1 | METHOD FOR PREPARING LYSOBACTIN DERIVATIVES | BAYER HEALTHCARE AG (DE) | 2009-06-25 | — | — | US | disclosed |
| EP-2007794-A1 | LYSOBACTIN AMIDES | AiCuris GmbH & Co. KG (DE) | 2008-12-31 | — | — | EP | disclosed |
| EP-2004670-A1 | PROCESS FOR THE MANUFACTURE OF LYSOBACTIN DERIVATIVES | AiCuris GmbH & Co. KG (DE) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007118693-A1 | PROCESS FOR THE MANUFACTURE OF LYSOBACTIN DERIVATIVES | AICURIS GMBH & CO. KG (DE) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007118691-A1 | LYSOBACTIN AMIDES | AICURIS GMBH & CO. KG (DE) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163696-A1 | METHOD FOR PREPARING LYSOBACTIN DERIVATIVES | DLST, VIP, HAMP | SLC15A1 1459/4885ALDH1A1 4567/4885KMT2A 1908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.